전체 글 274

이버멕틴은 간 성상 세포 활성화를 억제하여 마우스에서 CCl4- 유도된 간 섬유증을 약화시킵니다.

2022년 12월 Ivermectin 은 간 성상 세포 활성화를 억제하여 마우스에서 CCl4- 유도된 간 섬유증을 약화시킵니다. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782196/ Ivermectin Attenuates CCl4-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation Liver fibrosis, a common liver dysfunction with high morbidity and mortality rates, is the leading cause of cirrhosis and hepatocellular carcinoma, for which there ar..

심한 질 근육병: Ivermectin으로 성공적인 관리

2022년 6월 17일. 심한 질 근육병: Ivermectin으로 성공적인 관리 https://pubmed.ncbi.nlm.nih.gov/35718295/ Severe Vaginal Myiasis: Successful Management With Ivermectin - PubMed Myiasis refers to infestation of living animals or humans by maggots or fly larvae. Urogenital myiasis is a rare condition that is linked to poor sanitary conditions and limited access to healthcare and with few published case reports. Here..

COVID-19의 치료 및/또는 예방을 위한 이버멕틴의 용도 변경 가능성

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506580/ Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19 Due to the rapid, vast, and emerging global spread of the Coronavirus Disease 2019 (COVID-19) pandemic, many drugs were quickly repurposed in a desperate attempt to unveil a miracle drug. Ivermectin (IVM), an antiparasitic macrocyclic ..

카테고리 없음 2023.01.11